Search Results

May 29, 2019  

New Ownership, Name for VenBio

(SEE CORRECTION BELOW) The owner of VenBio Select Advisor, a $2.2 billion biotechnology-focused fund manager with an outstanding track record, has sold a 50% interest in the business to healthcare investor Garheng Kong.Kong, who owns growth-equity investment firm HealthQuest Capital of Belmont, Calif., paid an undisclosed sum to venBio portfolio manager Behzad Aghazadeh for the stake. The transaction closed on May 3, at which point venBio changed...

This article is free to subscribers of Hedge Fund Alert. If you are a subscriber, please sign in.

If you are not a subscriber, please complete the form below to purchase the article for $19.95.
First Name *
Last Name *
E-mail *
Card Number *
Expiration *
Card Code *
Address *
City *
State/Province *
Zip/Postal Code *

Purchase Article